Zacks Research Issues Positive Forecast for Integer Earnings

Integer Holdings Co. (NYSE:ITGR) – Analysts at Zacks Research boosted their Q1 2026 EPS estimates for Integer in a note issued to investors on Thursday, May 15th. Zacks Research analyst R. Department now anticipates that the medical equipment provider will earn $1.61 per share for the quarter, up from their prior estimate of $1.59. The consensus estimate for Integer’s current full-year earnings is $6.01 per share. Zacks Research also issued estimates for Integer’s Q2 2026 earnings at $1.62 EPS.

Several other brokerages have also commented on ITGR. Benchmark lowered their price objective on shares of Integer from $150.00 to $140.00 and set a “buy” rating for the company in a report on Friday, April 25th. Truist Financial set a $150.00 price objective on shares of Integer and gave the stock a “buy” rating in a report on Friday, April 25th. KeyCorp lowered their target price on shares of Integer from $154.00 to $145.00 and set an “overweight” rating for the company in a report on Monday, April 21st. StockNews.com upgraded shares of Integer from a “sell” rating to a “hold” rating in a report on Monday. Finally, Oppenheimer lowered shares of Integer from an “outperform” rating to a “market perform” rating in a report on Friday, February 21st. Three analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, Integer presently has an average rating of “Moderate Buy” and a consensus price target of $145.56.

Integer Stock Performance

Shares of ITGR opened at $121.51 on Monday. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. Integer has a one year low of $104.93 and a one year high of $146.36. The company has a 50-day simple moving average of $118.41 and a two-hundred day simple moving average of $129.42. The firm has a market capitalization of $4.24 billion, a PE ratio of 36.16, a price-to-earnings-growth ratio of 1.72 and a beta of 1.03.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. Integer had a net margin of 6.92% and a return on equity of 11.65%. The business had revenue of $437.39 million during the quarter, compared to analyst estimates of $428.51 million. During the same period last year, the business posted $1.14 earnings per share. Integer’s quarterly revenue was up 7.3% compared to the same quarter last year.

Institutional Investors Weigh In On Integer

A number of large investors have recently added to or reduced their stakes in ITGR. Capital Research Global Investors boosted its stake in shares of Integer by 16.0% during the 4th quarter. Capital Research Global Investors now owns 1,410,803 shares of the medical equipment provider’s stock worth $186,960,000 after acquiring an additional 194,895 shares during the last quarter. Loomis Sayles & Co. L P lifted its stake in Integer by 3.8% in the 4th quarter. Loomis Sayles & Co. L P now owns 558,715 shares of the medical equipment provider’s stock worth $74,041,000 after purchasing an additional 20,688 shares in the last quarter. Congress Asset Management Co. increased its holdings in shares of Integer by 4.9% in the 1st quarter. Congress Asset Management Co. now owns 522,656 shares of the medical equipment provider’s stock worth $61,679,000 after buying an additional 24,306 shares during the last quarter. Driehaus Capital Management LLC increased its holdings in shares of Integer by 5.5% in the 4th quarter. Driehaus Capital Management LLC now owns 451,464 shares of the medical equipment provider’s stock worth $59,828,000 after buying an additional 23,706 shares during the last quarter. Finally, Northern Trust Corp increased its holdings in shares of Integer by 14.2% in the 4th quarter. Northern Trust Corp now owns 422,380 shares of the medical equipment provider’s stock worth $55,974,000 after buying an additional 52,556 shares during the last quarter. Institutional investors own 99.29% of the company’s stock.

Insider Activity at Integer

In related news, CEO Joseph W. Dziedzic sold 338,975 shares of the firm’s stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the completion of the sale, the chief executive officer now owns 47,000 shares of the company’s stock, valued at $5,788,990. This trade represents a 87.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.16% of the stock is owned by insiders.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.